Shares of Synthomer plc (LON:SYNT - Get Free Report) traded down 9.5% during trading on Wednesday after Berenberg Bank lowered their price target on the stock from GBX 375 to GBX 340. Berenberg Bank currently has a buy rating on the stock. Synthomer traded as low as GBX 226 ($2.89) and last traded at GBX 226.80 ($2.90). 12,255,630 shares changed hands during mid-day trading, an increase of 2,272% from the average session volume of 516,593 shares. The stock had previously closed at GBX 250.50 ($3.20).
Separately, Jefferies Financial Group raised their price target on Synthomer from GBX 220 ($2.81) to GBX 250 ($3.19) and gave the stock a "hold" rating in a research report on Friday, July 12th.
Get Our Latest Stock Analysis on Synthomer
Synthomer Price Performance
The company has a debt-to-equity ratio of 79.72, a quick ratio of 0.97 and a current ratio of 1.95. The company has a market cap of £368.85 million, a price-to-earnings ratio of -187.92, a PEG ratio of -0.17 and a beta of 1.76. The business has a fifty day moving average price of GBX 266.91 and a 200 day moving average price of GBX 240.48.
Synthomer Company Profile
(
Get Free Report)
Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.
See Also
Before you consider Synthomer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.
While Synthomer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.